Profile picture

Doctor Alexander Christian Falkentoft

Zealand University Hospital, Roskilde (Denmark)
Follow
Logo ESC

Contributor content

Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
Presentation
Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
The impact of statins and RAS inhibitors on the association between delayed antidiabetic treatment and the risk of cardiovascular event in patients with a first HbA1c between 48-57 mmol/mol
Presentation
The impact of statins and RAS inhibitors on the association between delayed antidiabetic treatment and the risk of cardiovascular event in patients with a first HbA1c between 48-57 mmol/mol
Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study
Presentation
Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study
Socioeconomic position influences the risk of first-time cardiovascular event in patients with type 2 diabetes in spite of equal access to healthcare - a Danish nationwide cohort study
Presentation
Socioeconomic position influences the risk of first-time cardiovascular event in patients with type 2 diabetes in spite of equal access to healthcare - a Danish nationwide cohort study
Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction
Presentation
Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction

ESC 365 is supported by